Table 2.
Supplementation phase | Decrease in H. pylori | Increase in H. pylori |
---|---|---|
Baseline (day 1) – day 28 | 11 (45.8) | 13 (54.2) |
Day 29 – day 56 | 15 (62.5) | 9 (37.5) |
Number of subjects (%) who experienced a decrease/increase in H. pylori load as evaluated by the means of 13C UBT after placebo (day 1 -day 28) and after 4 weeks (day 29-56) of Pylopass™ supplementation (n = 24)